| Literature DB >> 16839865 |
Richard D Kenagy1, Anna H Plaas, Thomas N Wight.
Abstract
Versican is an abundant proteoglycan in the blood vessel wall that is increased after vascular injury and accumulates in advanced atherosclerotic plaques. Versican is a large molecule with domains that mediate binding to cytokines, enzymes, lipoproteins, other extracellular matrix molecules, and signaling receptors. There is evidence that versican exists in the normal, as well as the diseased, vessel wall as discrete fragments, which represent these functional domains. We review the literature on versican degradation in vascular tissue and the function of versican domains, all of which suggest that proteolytic modification of versican may have physiologic as well as pathologic implications for the vascular system.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16839865 PMCID: PMC3169384 DOI: 10.1016/j.tcm.2006.03.011
Source DB: PubMed Journal: Trends Cardiovasc Med ISSN: 1050-1738 Impact factor: 6.677